Found 78 matching trials
Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana PHASE4 The goal of this this hybrid safety/implementation study is to evaluate whe...
Show More Status
Active Not Recruiting
Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma NA The goal of this clinical trial is to evaluate the efficacy and safety of d...
Show More Location
Shanghai Public Health Clinical Center
Learn More & Join Trial
Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. PHASE3 The purpose of this study is to evaluate if offering long-acting injectable...
Show More Location
Hôpital Hôtel Dieu
Learn More & Join Trial
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults PHASE3 This Antiretroviral Therapy as Long Acting Suppression every 2 Months (ATLA...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
Oregon PrEP at Home Study N/A This demonstration study will evaluate the real-world implementation of lon...
Show More Location
Oregon Health & Science University
Learn More & Join Trial
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum N/A The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Show More Learn More & Join Trial
Optimizing CAB-LA as PrEP for Women Who Inject Drugs N/A The goal of this study is to elicit information crucial for designing strat...
Show More Location
Prevention Point Philadelphia
Learn More & Join Trial
Long-Acting Treatment in Adolescents (LATA) PHASE3 The LATA trial will find out if taking a long-acting injectable form of HIV...
Show More Learn More & Join Trial
A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects PHASE2 This study is a Phase IIb, randomized, multicentre, parallel group, open-la...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV N/A The CABOTEGRAVIR Long Acting + RILPIVIRENE Long Acting regimen was currentl...
Show More Status
Active Not Recruiting
Location
Hospital Universitario Virgen de Las Nieves
Learn More & Join Trial